zidovudine has been researched along with Central Nervous System Diseases in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Liu, X; Shu, J; Tang, SJ; Wu, T; Yang, Y; Zhang, W | 1 |
| Armstrong, FD; Seidel, JF; Swales, TP | 1 |
| Elovaara, I; Hokkanen, L; Lähdevirta, J; Mattinen, S; Poutiainen, E; Raininko, R; Ranki, A; Suni, J; Virta, A | 1 |
| Hentzen, BT; Schreij, G | 1 |
| Domachowske, JB | 1 |
| Baker, CJ; Brouwers, P; Englund, JA; Jimenez, E; Lifschitz, MH; McKinney, RE; Mintz, M; Nozyce, M; O'Donnell, K; Pearson, DA; Raskino, C | 1 |
| Arendt, G; Hefter, H; Theisen, A; von Giesen, HJ | 1 |
| Cruz-Sánchez, FF | 1 |
| Hirabayashi, Y; Kikuchi, Y; Kimura, S; Mitamura, K; Oka, S; Shimada, K; Toyoshima, T | 1 |
| Bennett, JM; Cohen, P; Kahn, J; Kaplan, L; Levine, AM; Metroka, C; Rarick, MU; Rodman, N; Walsh, C; Wernz, JC | 1 |
| Bodsworth, N; Cooper, DA; Cotton, R; Imrie, A; Perdices, M; Swanson, C; Tindall, B | 1 |
| Bader, L; Eberle, J; Günther, W; Gürtler, L; Naber, D; Riedel, RR | 1 |
| Dalakas, M; Sever, J; Wichman, A | 1 |
| Brady, RO; O'Neill, RR | 1 |
| Jaenisch, R; Ruprecht, RM; Sharpe, AH | 1 |
| Brew, BJ; Price, RW; Rosenblum, M | 1 |
| Cload, P; Danner, SA; de Gans, J; de Wolf, F; Derix, MM; Eeftinck Schattenkerk, JK; Goudsmit, J; Lange, JM; Ongerboer de Visser, BW | 1 |
5 review(s) available for zidovudine and Central Nervous System Diseases
| Article | Year |
|---|---|
Pediatric HIV infection: a neuropsychological and educational challenge.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Central Nervous System Diseases; Child; Child Behavior Disorders; Child, Preschool; Cognition Disorders; Developmental Disabilities; Female; HIV Seropositivity; Humans; Immunosuppression Therapy; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Zidovudine | 1993 |
Pediatric human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Central Nervous System Diseases; Child; Child, Preschool; Cytomegalovirus Infections; Didanosine; Disease Transmission, Infectious; Eye Diseases; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Herpes Simplex; Herpes Zoster; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Neoplasms; Pregnancy; Prevalence; Risk Factors; Sexual Behavior; Skin Diseases; Transfusion Reaction; Zidovudine | 1996 |
[Azidothymidine and the nervous system].
Topics: AIDS Dementia Complex; Cell Fusion; Central Nervous System Diseases; Neurons; Thymidine Kinase; Zidovudine | 1991 |
AIDS and the nervous system.
Topics: Acquired Immunodeficiency Syndrome; Adult; Central Nervous System Diseases; Dementia; Humans; Male; Nervous System Diseases; Neuromuscular Diseases; Opportunistic Infections; Peripheral Nervous System Diseases; Zidovudine | 1989 |
AIDS dementia complex and primary HIV brain infection.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Central Nervous System Diseases; Dementia; Humans; Meningitis, Aseptic; Syndrome; Zidovudine | 1988 |
5 trial(s) available for zidovudine and Central Nervous System Diseases
| Article | Year |
|---|---|
Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection.
Topics: Adult; beta 2-Microglobulin; CD4-CD8 Ratio; Central Nervous System Diseases; Cognition Disorders; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulin G; Male; Middle Aged; Zidovudine | 1994 |
Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team.
Topics: Adolescent; Analysis of Variance; Anti-HIV Agents; Brain; Central Nervous System Diseases; Child; Child, Preschool; Cognition; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Intelligence Tests; Male; Motor Skills; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection.
Topics: Adult; Anti-HIV Agents; Central Nervous System Diseases; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Motor Skills; Stavudine; Zalcitabine; Zidovudine | 2001 |
A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection.
Topics: Adolescent; Adult; Anorexia; CD4-Positive T-Lymphocytes; Central Nervous System Diseases; HIV Infections; HIV-1; Humans; Japan; Leukocyte Count; Leukopenia; Male; Nausea; Risk Factors; Zidovudine | 1992 |
Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Diseases; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prospective Studies; Vincristine; Zidovudine | 1991 |
8 other study(ies) available for zidovudine and Central Nervous System Diseases
| Article | Year |
|---|---|
Quercetin attenuates AZT-induced neuroinflammation in the CNS.
Topics: Animals; Anti-HIV Agents; Antioxidants; Astrocytes; Central Nervous System Diseases; Cytokines; Disease Models, Animal; Mice; Quercetin; Wnt-5a Protein; Zidovudine | 2018 |
Patterns of morbidity and mortality in AIDS patients on Pneumocystis carinii prophylaxis who died during hospital admission: a report of 50 diseased patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cause of Death; Central Nervous System Diseases; Comorbidity; Female; Humans; Male; Middle Aged; Netherlands; Pneumonia, Pneumocystis; Survival Analysis; Zidovudine | 1996 |
[Human immunodeficiency virus infection and neurological changes].
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Brain Diseases; Central Nervous System Diseases; Cognition Disorders; HIV-1; Humans; Nervous System Diseases; Peripheral Nervous System Diseases; Risk Factors; Zidovudine | 1992 |
Feedback from the Sixth International AIDS Conference, San Francisco 1990.
Topics: Acquired Immunodeficiency Syndrome; Central Nervous System Diseases; Equipment Contamination; Female; Health Workforce; HIV Infections; Humans; Male; Occupational Diseases; Pregnancy; Pregnancy Complications, Infectious; Substance Abuse, Intravenous; Transfusion Reaction; Zidovudine | 1991 |
Fifth International Conference on the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Allied Health Personnel; Central Nervous System Diseases; Child, Preschool; Congresses as Topic; Costs and Cost Analysis; Female; Global Health; Health Education; Humans; Infant; Infant, Newborn; Male; Opportunistic Infections; Pregnancy; Prejudice; Public Health; Quebec; Research; Vaccines; World Health Organization; Zidovudine | 1990 |
Therapy for neurological involvement in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Blood-Brain Barrier; Central Nervous System Diseases; Deoxycytidine; Humans; Immunotherapy; Molecular Biology; Retroviridae; Thymidine; Zalcitabine; Zidovudine | 1988 |
Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapy.
Topics: Animals; Animals, Newborn; Antiviral Agents; Central Nervous System Diseases; Female; Fetal Diseases; Gestational Age; Maternal-Fetal Exchange; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Retroviridae; Thymidine; Tumor Virus Infections; Virulence; Zidovudine | 1987 |
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Central Nervous System Diseases; HIV; HIV Antigens; Humans; Male; Thymidine; Time Factors; Virus Replication; Zidovudine | 1988 |